Therapeutic Asset Ratings

6,308 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Ibuprofen Oropharyngeal Carcinoma	National Cancer Institute (NCI)	P1/2	CCC (48)
Ibuprofen Reproductive System Cancer	National Cancer Institute (NCI)	P1/2	CCC (48)
Icasp9M28Z T Cell Infusions Pleural Cancer	Memorial Sloan Kettering Cancer Center	P1/2	CCC (48)
Icp-490 Plasma Cell Myeloma	Beijing InnoCare Pharma Tech Co., Ltd.	P1/2	CCC (48)
Icp-490 Non-Hodgkin Lymphoma	Beijing InnoCare Pharma Tech Co., Ltd.	P1/2	CCC (48)
ict01 Hematopoietic And Lymphoid System Neoplasm	ImCheck Therapeutics	P1/2	CCC (48)
ide161 Neuroendocrine Carcinoma	IDEAYA Biosciences	P1/2	CCC (48)
ide849 Neuroendocrine Carcinoma	IDEAYA Biosciences	P1/2	CCC (48)
Idp-001 Anal Squamous Cell Carcinoma	InduPro, Inc.	P1/2	CCC (48)
Idp-001 Cervical Squamous Cell Carcinoma	InduPro, Inc.	P1/2	CCC (48)
Idp-001 Esophageal Squamous Cell Carcinoma	InduPro, Inc.	P1/2	CCC (48)
Idp-121 High-Grade B-Cell Lymphoma Double-Hit/Triple-Hit	IDP Discovery Pharma S.L.	P1/2	CCC (48)
Ifebemtinib Neoplasm	InxMed (Shanghai) Co., Ltd.	P1/2	CCC (48)
IMA401 Refractory Malignant Neoplasm	Immatics Biotechnologies GmbH	P1/2	CCC (48)
ima402 Cancer	Immatics Biotechnologies GmbH	P1/2	CCC (48)
Imgn632 Mixed Phenotype Acute Leukemia	Fred Hutchinson Cancer Center	P1/2	CCC (48)
Imgn632 T-Cell Acute Lymphoblastic Leukemia	Children's Oncology Group	P1/2	CCC (48)
Imgn632 Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia	Children's Oncology Group	P1/2	CCC (48)
IMM-1-104 Cutaneous Melanoma	Immuneering Corporation	P1/2	CCC (48)
Immunoglobulin G1 [101-Glycine,234-Phenylalanine,235-Glutamic Acid,265-Alanine,405-Leucine,De-C-Terminal-Lysine], Anti-(Human Cd3 Antigen) (Human-Mus Musculus Monoclonal Igg1-Hucacao-H101G-Feal ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Igg1-Hucacao-H101G-Feal ?-Chain, (234?226?),(237?229?)-Bis(Disulfide) With Immunoglobulin G1 [234-Phenylalanine,235-Glutamic Acid,265-Alanine,409-Arginine] Anti-(Human B7 Homolog 4 Protein) (Human Monoclonal Igg1-7724-084-N52S-Fear ?1-Chain) Disulfide With Human Monoclonal Igg1-7724-084-N52S-Fear ?-Chain Breast Cancer	Genmab	P1/2	CCC (48)
Immunoglobulin G1 [101-Glycine,234-Phenylalanine,235-Glutamic Acid,265-Alanine,405-Leucine,De-C-Terminal-Lysine], Anti-(Human Cd3 Antigen) (Human-Mus Musculus Monoclonal Igg1-Hucacao-H101G-Feal ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Igg1-Hucacao-H101G-Feal ?-Chain, (234?226?),(237?229?)-Bis(Disulfide) With Immunoglobulin G1 [234-Phenylalanine,235-Glutamic Acid,265-Alanine,409-Arginine] Anti-(Human B7 Homolog 4 Protein) (Human Monoclonal Igg1-7724-084-N52S-Fear ?1-Chain) Disulfide With Human Monoclonal Igg1-7724-084-N52S-Fear ?-Chain Endometrial Cancer	Genmab	P1/2	CCC (48)
Immunoglobulin G1 [101-Glycine,234-Phenylalanine,235-Glutamic Acid,265-Alanine,405-Leucine,De-C-Terminal-Lysine], Anti-(Human Cd3 Antigen) (Human-Mus Musculus Monoclonal Igg1-Hucacao-H101G-Feal ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Igg1-Hucacao-H101G-Feal ?-Chain, (234?226?),(237?229?)-Bis(Disulfide) With Immunoglobulin G1 [234-Phenylalanine,235-Glutamic Acid,265-Alanine,409-Arginine] Anti-(Human B7 Homolog 4 Protein) (Human Monoclonal Igg1-7724-084-N52S-Fear ?1-Chain) Disulfide With Human Monoclonal Igg1-7724-084-N52S-Fear ?-Chain Ovarian Cancer	Genmab	P1/2	CCC (48)
Immunoglobulin G1 [101-Glycine,234-Phenylalanine,235-Glutamic Acid,265-Alanine,405-Leucine,De-C-Terminal-Lysine], Anti-(Human Cd3 Antigen) (Human-Mus Musculus Monoclonal Igg1-Hucacao-H101G-Feal ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Igg1-Hucacao-H101G-Feal ?-Chain, (234?226?),(237?229?)-Bis(Disulfide) With Immunoglobulin G1 [234-Phenylalanine,235-Glutamic Acid,265-Alanine,409-Arginine] Anti-(Human B7 Homolog 4 Protein) (Human Monoclonal Igg1-7724-084-N52S-Fear ?1-Chain) Disulfide With Human Monoclonal Igg1-7724-084-N52S-Fear ?-Chain Non-Small Cell Squamous Lung Carcinoma	Genmab	P1/2	CCC (48)
Immunoglobulin G1 [240-alanine,241-alanine], anti-(human folate receptor ?) (human monoclonal PRO1184 ?1-chain, complex with human monoclonal PRO1184 ?-chain, dimer, 214??,214???,226,226?,232,232?,235,235?-octakis(thioether) with N6-[39-[bis(1-deoxy-D-glucitol-1-yl)amino]-1-oxo-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxanonatriacont-1-yl]-N2-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]-L-lysyl-L-valyl-N5-(aminocarbonyl)-N-[4-[[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-1-yl]amino]carbonyl]oxy]methyl]phenyl]-L-ornithinamide Ovarian Carcinoma	Genmab	P1/2	CCC (48)
Immunoglobulin G1 [240-alanine,241-alanine], anti-(human folate receptor ?) (human monoclonal PRO1184 ?1-chain, complex with human monoclonal PRO1184 ?-chain, dimer, 214??,214???,226,226?,232,232?,235,235?-octakis(thioether) with N6-[39-[bis(1-deoxy-D-glucitol-1-yl)amino]-1-oxo-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxanonatriacont-1-yl]-N2-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]-L-lysyl-L-valyl-N5-(aminocarbonyl)-N-[4-[[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-1-yl]amino]carbonyl]oxy]methyl]phenyl]-L-ornithinamide Breast Tumor Luminal A Or B	Genmab	P1/2	CCC (48)

Showing 1326 to 1350 of 6,308 assets

PreviousPage 54 of 253Next